...
首页> 外文期刊>Current pediatric reviews >Emollient Acceptability in Childhood Atopic Dermatitis: Not All Emollients are Equal
【24h】

Emollient Acceptability in Childhood Atopic Dermatitis: Not All Emollients are Equal

机译:儿童的润肤剂可接受性是特应性皮炎:并非所有润肤剂都是平等的

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Eczema or Atopic Dermatitis (AD) is a common chronic relapsing skindisease associated with impaired quality of life. Regular usage of moisturizer/emollient is the mainstayof management but acceptability of emollient is often suboptimal. We investigated if emollientacceptability is influenced by various clinical factors in AD.Methods: A survey on frequency of emollient usage, brands, clinical factors including disease severity(Nottingham Eczema Severity Score, NESS), quality of life (Children Dermatology LifeQuality Index, CDLQI), Transpidermal Water Loss (TEWL), and Skin Hydration (SH) was performed.Acceptability was classified as very good, good, fair or poor.Results: We evaluated 128 AD patients. NESS correlated with CDLQI and the treatment domain ofCDLQI. Emollient usage is elementary for AD treatment. 89.1% of patients reported that doctor’srecommendation was the major source of advice when choosing an emollient. Aqueous cream (AQ)and petroleum-derived products were among the commonly used emollients. More aqueous creamusers reported fair/poor acceptability (p=0.017) and lower SH (p<0.05). Linear regression showedthat patients who thought their emollient as fair or poor were currently using AQ (p=0.003), theiremollient not recommended by a doctor (p=0.035), with more severe disease (p=0.04), and hadlower emollient usage in winter (p=0.05).Conclusion: Physicians play a pivotal role in assisting patients to select an emollient that they willaccept and use consistently. The studied emollients are generally acceptable by over 80% patients.However, aqueous cream is least acceptable by patients, making it the least favorable emollient torecommend to patients.
机译:背景:湿疹或特应性皮炎(AD)是一种常见的慢性复发性Skindisease,与生活质量受损相关。定期使用保湿霜/润肤剂是管理的主要管理,但润肤剂的可接受性通常是次优。我们调查了助剂受助剂受到临床因素的影响。方法:助剂使用量,品牌,疾病严重程度(诺丁汉湿疹严重程度,NESS),生活质量(儿童皮肤病学救命指数,CDLQI)频率调查,进行杂项水分损失(TEWL)和皮肤水合(SH)。可接受性被归类为非常好,良好,公平或穷人。结果:我们评估了128名AD患者。 NESS与CDLQI和CDLQI的治疗领域相关联。润肤用法是广告治疗的基本内容。 89.1%的患者报告说,在选择润肤方时,医生的咨询是主要建议的主要来源。含水霜(水溶液)和石油衍生的产品是常用的润肤剂中。更多含水乳膏剂报告公平/可接近可接受性(P = 0.017)和下SH(P <0.05)。线性回归展示患者作为公平或贫困的患者目前使用AQ(P = 0.003),未经医生(P = 0.035)推荐的重大患者(P = 0.035),具有更严重的疾病(P = 0.04),以及冬季Hadlower润肤剂使用(p = 0.05).Conclusion:医生在协助患者选择一个润肤剂并始终使用的润肤剂来发挥关键作用。通过80%的患者通常可以接受研究。然而,含水霜是患者最不可接受的,使其成为患者最不利的润肤品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号